Hutch News

New Science Spotlight Articles

Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
10 NEW August 26, 2019

5 questions on new dengue vaccine analysis

Asked to help re-examine clinical trial data, Fred Hutch biostatisticians foresee a new era of personalized vaccines
Hutch News - June 20, 2018

Appelbaum editorial: Evidence tips transplant practice back to bone marrow

In New England Journal of Medicine editorial, Fred Hutchinson Cancer Research Center’s Dr. Fred Appelbaum argues adult stem cells harvested from bone marrow rather than blood of unrelated donors are best for reducing graft-vs.-host disease risk
Hutch News - October 22, 2012

Patient's cloned T cells kill tumors

Case is first to show safety and effectiveness of using infection-fighting T cells alone to put late-stage melanoma into long-term remission
Hutch News - June 23, 2008

The troubling global trend for breast cancer

With greater affluence comes a global increase in breast-cancer risk, reports cancer biology researcher Peggy Porter
Hutch News - January 28, 2008

For the First Time a Molecular Test Proves to be Effective in Measuring the Extent of Remission After Cancer Treatment and the Potential for Relapse

The molecular test is already saving lives of patients who relapse after bone-marrow or stem-cell transplantation. Researchers now predict that the approach will speed the delivery of promising new therapies to other patients
Releases - October 08, 2003

From Criminology to Seeking a Cure for Cancer — Today's DNA Analytical Tools Make Possible What Was Once Unthinkable

Fred Hutchinson Cancer Research Center finds that in some cases a mismatched donor may work for leukemia patients — expanding the donor pool and increasing opportunity for people seeking lifesaving treatment
Releases - December 19, 2001
Last Modified, August 15, 2019